NYSE: $NUVB A Major Milestone in Brain Cancer Research Nuvation Bio has announced a significant development in the fight against brain cancer. The U.S. Food and Drug Administration (FDA) has officially granted Fast Track designation to their investigational drug, safusidenib, for the treatment of patients with IDH1-mutant glioma. What This Means for Patients The FDA’s…